Herbal remedy trial aims to protect kidneys during cancer drug therapy
NCT ID NCT07358520
Summary
This study is testing whether Huaier Granules, an herbal medicine, can help control a kidney side effect called proteinuria in lung cancer patients. Proteinuria is a common problem for patients taking the cancer drugs Bevacizumab or Anlotinib. The trial will compare patients who take the granules to those who don't, to see if it helps reduce protein in their urine and allows them to continue their cancer treatment.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PROTEINURIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-••••
Locations
-
Xin Hua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine
Shanghai, Shanghai Municipality, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Xuzhou Central Hospital
Xuzhou, Jiangsu, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.